FDA faults Invacare s compliance: Production at Elyria headquarters could be suspended due to regulations
ELYRIA Production at Invacare s Elyria headquarters could be suspended pending compliance with Food and Drug Administration regulations, according to Invacare spokeswoman Lara Mahoney.

FDA Tells Weight-Loss Surgery Centers To Pull Misleading Ads
The Food and Drug Administration has warned a marketing company and eight surgery centers in Southern California that their marketing of weight-loss surgery is misleading. Ads touted the benefits without adequately describing the risks.